Changjiang Lei

527 total citations
26 papers, 384 citations indexed

About

Changjiang Lei is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Changjiang Lei has authored 26 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Changjiang Lei's work include Cancer-related molecular mechanisms research (7 papers), RNA Research and Splicing (5 papers) and RNA modifications and cancer (3 papers). Changjiang Lei is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), RNA Research and Splicing (5 papers) and RNA modifications and cancer (3 papers). Changjiang Lei collaborates with scholars based in China. Changjiang Lei's co-authors include Mingyi Li, Zhidong Qiu, Huilai Miao, Zhixiong Long, Gang Zheng, Ying Huang, Xia Gao, Jiarui Feng, Jianbin Huang and Ran Li and has published in prestigious journals such as The International Journal of Biochemistry & Cell Biology, Journal of Cellular Biochemistry and Chemical Research in Toxicology.

In The Last Decade

Changjiang Lei

26 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changjiang Lei China 13 266 196 52 52 38 26 384
Xianju Qin China 12 260 1.0× 163 0.8× 70 1.3× 24 0.5× 48 1.3× 21 401
Tianwei Chen China 11 247 0.9× 133 0.7× 87 1.7× 54 1.0× 40 1.1× 25 421
Yuanchang Hu China 9 379 1.4× 221 1.1× 71 1.4× 65 1.3× 46 1.2× 14 502
Boyun Shi China 13 317 1.2× 206 1.1× 72 1.4× 36 0.7× 43 1.1× 16 439
Chuan-Chu Cheng Taiwan 11 237 0.9× 92 0.5× 89 1.7× 49 0.9× 20 0.5× 15 343
Yimin Xiong China 10 248 0.9× 153 0.8× 59 1.1× 20 0.4× 40 1.1× 16 375
Shi Li China 10 246 0.9× 155 0.8× 43 0.8× 61 1.2× 36 0.9× 19 344
Chen‐Hong Ding China 10 386 1.5× 224 1.1× 71 1.4× 43 0.8× 38 1.0× 21 533

Countries citing papers authored by Changjiang Lei

Since Specialization
Citations

This map shows the geographic impact of Changjiang Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjiang Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjiang Lei more than expected).

Fields of papers citing papers by Changjiang Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changjiang Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjiang Lei. The network helps show where Changjiang Lei may publish in the future.

Co-authorship network of co-authors of Changjiang Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Changjiang Lei. A scholar is included among the top collaborators of Changjiang Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changjiang Lei. Changjiang Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Wei, Yan Han, Changjiang Lei, & Xue Lin. (2024). LncRNA SNHG1 knockdown attenuates lipopolysaccharide-induced acute lung injury via regulating miR199a-3p/ROCK2 axis. General Physiology and Biophysics. 43(5). 399–409. 1 indexed citations
2.
Zheng, Gang, et al.. (2022). Does bariatric surgery really benefit patients before total knee arthroplasty? A systematic review and meta-analysis. International Journal of Surgery. 104. 106778–106778. 12 indexed citations
3.
Huang, Ying, et al.. (2021). LncRNA ACTA2-AS1 suppress colon adenocarcinoma progression by sponging miR-4428 upregulation BCL2L11. Cancer Cell International. 21(1). 203–203. 11 indexed citations
4.
Wang, Qun, Jing Wu, Wei Hua, et al.. (2021). JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1. The International Journal of Biochemistry & Cell Biology. 138. 106040–106040. 11 indexed citations
6.
Chen, Wei, et al.. (2021). Telmisartan Mitigates High-Glucose-Induced Injury in Renal Glomerular Endothelial Cells (rGECs) and Albuminuria in Diabetes Mice. Chemical Research in Toxicology. 34(9). 2079–2086. 8 indexed citations
8.
Wang, Qun, Jing Wu, Hui Huang, et al.. (2020). lncRNA LIFR-AS1 suppresses invasion and metastasis of non-small cell lung cancer via the miR-942-5p/ZNF471 axis. Cancer Cell International. 20(1). 180–180. 42 indexed citations
9.
Lei, Changjiang, Shixing Wu, Yuan Li, et al.. (2019). Zafirlukast attenuates advanced glycation end-products (AGEs)-induced degradation of articular extracellular matrix (ECM). International Immunopharmacology. 68. 68–73. 12 indexed citations
10.
Lei, Changjiang, Yao Yao, Bin Shen, et al.. (2019). <p>Columbamine suppresses the proliferation and malignization of colon cancer cells via abolishing Wnt/β-catenin signaling pathway</p>. Cancer Management and Research. Volume 11. 8635–8645. 15 indexed citations
11.
Lei, Changjiang, et al.. (2019). P2Y11R regulates cytotoxicity of HBV X protein (HBx) in human normal hepatocytes.. PubMed. 11(5). 2765–2774. 3 indexed citations
12.
Lei, Changjiang, Xiulan Peng, Ying Fan, et al.. (2019). Prognostic role of programmed death-ligand 1 expression in patients with biliary tract cancer: a meta-analysis. Aging. 11(24). 12568–12580. 12 indexed citations
13.
Gao, Xia, Changjiang Lei, Bin Zhu, et al.. (2016). miR-542-3p inhibits the growth and invasion of colorectal cancer cells through targeted regulation of cortactin. International Journal of Molecular Medicine. 37(4). 1112–1118. 29 indexed citations
14.
Lei, Changjiang, Jiani Liu, Rong Wu, et al.. (2016). Change of the peripheral blood immune pattern and its correlation with prognosis in patients with liver cancer treated by sorafenib. Asian Pacific Journal of Tropical Medicine. 9(6). 592–596. 11 indexed citations
15.
Lei, Changjiang, Chun Yao, Zhixiong Long, et al.. (2016). Effect of co-transfection of miR-520c-3p and miR-132 on proliferation and apoptosis of hepatocellular carcinoma Huh7. Asian Pacific Journal of Tropical Medicine. 9(9). 898–902. 15 indexed citations
16.
Lei, Changjiang, et al.. (2015). Hsa‐miR‐132 inhibits proliferation of hepatic carcinoma cells by targeting YAP. Cell Biochemistry and Function. 33(5). 326–333. 26 indexed citations
17.
Wang, Bin, Changjiang Lei, Rong Wu, et al.. (2015). Anti-tumor effect of LTA combined with 5-FU on H22 tumor bearing mice. Asian Pacific Journal of Tropical Medicine. 8(7). 560–564. 5 indexed citations
18.
Lei, Changjiang, et al.. (2014). Lentivirus vectors construction of SiRNA targeting interference GPC3 gene and its biological effects on liver cancer cell lines Huh-7. Asian Pacific Journal of Tropical Medicine. 7(10). 780–786. 4 indexed citations
19.
Lei, Changjiang, et al.. (2013). Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosis. Molecular Medicine Reports. 7(3). 969–974. 23 indexed citations
20.
Miao, Huilai, Changjiang Lei, Jinhua Wen, et al.. (2012). Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down‐regulation of YAP. Journal of Cellular Biochemistry. 114(3). 625–631. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026